Feature Channels: AIDS and HIV

Filters close
Released: 7-Aug-2020 8:05 PM EDT
Penn Medicine-Led Research Suggests Greater Access to Specific HIV and Tuberculosis Medications is Needed Worldwide
Perelman School of Medicine at the University of Pennsylvania

A specific combination of HIV and TB treatments, difficult to obtain in certain parts of the world, decreased mortality risk for patients with HIV and multidrug-resistant TB

Newswise: New Sugar-based Signature Identifies T Cells Where HIV Hides and Persists Despite Antiretroviral Therapy
Released: 7-Aug-2020 10:30 AM EDT
New Sugar-based Signature Identifies T Cells Where HIV Hides and Persists Despite Antiretroviral Therapy
Wistar Institute

Wistar scientists may have discovered a new way of identifying and targeting hidden HIV viral reservoirs during treatment with antiretroviral therapy (ART).

Released: 4-Aug-2020 11:55 AM EDT
ACTG Announces Launch of Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19
University of California, Los Angeles (UCLA), Health Sciences

The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.

Newswise: Caught in the act – microscopy reveals key detail in retrovirus replication
Released: 29-Jul-2020 8:35 AM EDT
Caught in the act – microscopy reveals key detail in retrovirus replication
Penn State College of Medicine

A protein that is critical for retrovirus replication may select viral genetic material for packaging within the nuclei of host cells, rather than in the cytoplasm, as was previously believed.

Newswise: Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
Released: 23-Jul-2020 11:00 AM EDT
Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.

Newswise: Pioneering method reveals dynamic structure in HIV
Released: 16-Jul-2020 3:15 PM EDT
Pioneering method reveals dynamic structure in HIV
University of Utah

The method reveals that the lattice, which forms the major structural component of the human immunodeficiency virus (HIV), is dynamic. The discovery of a diffusing lattice made from Gag and GagPol proteins, long considered to be completely static, opens up potential new therapies. The method can be applied to biomedical structure.

Newswise: Faculty Receive Grant to Explore the Impact of COVID-19 on People Living with HIV
Released: 16-Jul-2020 1:25 PM EDT
Faculty Receive Grant to Explore the Impact of COVID-19 on People Living with HIV
Rutgers School of Public Health

Rutgers faculty receive grant to study how the current pandemic impacts people living with HIV, who may be at heightened risk for severe illness from COVID-19 compared to the general population.

Released: 16-Jul-2020 6:05 AM EDT
HIV Alone Not a Risk Factor for Cavities in Children
Rutgers University-New Brunswick

Recent studies indicate HIV infection heightens the risk of dental cavities – but a Rutgers researcher has found evidence that the risk of cavities comes not from HIV itself but from a weakened immune system, which could be caused by other diseases.

Released: 13-Jul-2020 9:05 PM EDT
Medicine and Education Lag in the Delivery of Services to Enhance Health of Sexually Active Adolescent Gay-Identified Men
Rutgers University-New Brunswick

Young gay sexual minority men – especially Black and Latino youth – have their first sexual experiences at younger ages, emphasizing a need for comprehensive and inclusive sex education, according to Rutgers researchers.

Released: 10-Jul-2020 1:00 PM EDT
Health, Bioethics Experts and Advocates Publish Guidance for Research on HIV, Co-infections in Pregnancy
University of North Carolina School of Medicine

The PHASES Working Group, co-led by researchers at UNC-Chapel Hill, Georgetown, and Johns Hopkins, launched ethics guidance at hivpregnancyethics.org, in a project dedicated to ending the evidence gap for pregnant women around HIV and co-infections.

8-Jul-2020 4:55 PM EDT
New $3.7M grant to support research exploring mysterious link between cancer, HIV/AIDS
Case Western Reserve University

Research has found that those living with HIV have a higher risk for certain kinds of cancers—such as lung cancer. Now, with a new five-year, $3.7 million grant from the National Cancer Institute, researchers from Case Western Reserve University hope to find out why.

Released: 8-Jul-2020 4:30 PM EDT
Nurses and Midwives Take the Lead in Providing HIV Services in Eastern and Southern Africa
Wolters Kluwer Health: Lippincott

“Nurse-initiated and managed antiretroviral therapy” (NIMART) is an innovative approach to making effective medications more accessible to people living with HIV (PLWH) in low-resource countries. A new study identifies challenges and opportunities to promoting nurse- and midwife-led HIV services in eastern and southern Africa, reports the July/August issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Released: 6-Jul-2020 1:45 PM EDT
UAlbany Establishes Center for HIV Research to Address Epidemic
University at Albany, State University of New York

The new Center for Collaborative HIV Research in Practice and Policy at the University at Albany will address the public health and social justice challenges of persons placed at risk for, or living with, HIV and related diseases.

Newswise: School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
Released: 29-Jun-2020 7:35 PM EDT
School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.

Released: 29-Jun-2020 9:30 AM EDT
Mount Sinai Researchers Find That COVID-19 Patients with HIV Did Not Experience Poorer Outcomes
Mount Sinai Health System

Patients with HIV who were hospitalized with COVID-19 did not experience poorer outcomes compared to a similar comparison group of patients.

Newswise: AACN Honors ‘5B’ Nurses Who Transformed Care for Patients With AIDS
Released: 25-Jun-2020 11:50 AM EDT
AACN Honors ‘5B’ Nurses Who Transformed Care for Patients With AIDS
American Association of Critical-Care Nurses (AACN)

Nurses Alison Moëd and Cliff Morrison will receive AACN Pioneering Spirit Awards for their efforts to transform treatment for patients with AIDS in the early 1980s. Together, they created the San Francisco Model, a patient-centered approach that improved the care for their patients and countless others around the world.

19-Jun-2020 3:25 PM EDT
New drug candidate reawakens sleeping HIV in hopes of functional cure
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a next-generation drug called Ciapavir (SBI-0953294) that is effective at reactivating dormant human immunodeficiency virus (HIV). The research, published in Cell Reports Medicine, aims to create a functional HIV cure by activating and then eliminating all pockets of dormant HIV—an approach called “shock and kill.”

Released: 22-Jun-2020 5:50 PM EDT
ACTG Studies at AIDS 2020: Virtual
University of California, Los Angeles (UCLA), Health Sciences

Topics include the efficacy and safety of third-line treatment regimens in resource-limited settings, viral rebound rates after treatment interruption of modern ART, and whether a standardized frailty score can improve clinicians’ ability to estimate cardiovascular risk among older people with HIV.

Newswise: Satya Dandekar honored with prestigious NIH MERIT award for HIV research
Released: 22-Jun-2020 4:55 PM EDT
Satya Dandekar honored with prestigious NIH MERIT award for HIV research
UC Davis Health

Satya Dandekar, professor of microbiology and chairperson of the Department of Medical Microbiology and Immunology at UC Davis, honored by Prestigious NIH MERIT award for her illustrious journey in HIV research.

Newswise: UCLA receives nearly $14 million from NIH to investigate gene therapy to combat HIV
Released: 15-Jun-2020 5:10 PM EDT
UCLA receives nearly $14 million from NIH to investigate gene therapy to combat HIV
University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.

Newswise: History of insightful HIV research inspires neutron scattering approach to studying COVID-19
Released: 12-Jun-2020 5:45 PM EDT
History of insightful HIV research inspires neutron scattering approach to studying COVID-19
Oak Ridge National Laboratory

What began as novel investigations into HIV, abruptly pivoted to the novel coronavirus as it began to spread across the globe. Now, ORNL researchers are using neutrons to learn more about the SARS-CoV-2 protease—a protein enzyme that enables the virus to replicate within the human body. Insights on the protein structure and its behaviors will be used to create more accurate models for simulations in aims of finding drug inhibitors to block the virus’s ability to reproduce.

Released: 1-Jun-2020 8:05 AM EDT
COVID-19 in People Living with HIV
Rutgers University-New Brunswick

Rutgers expert explains why COVID-19 pandemic poses additional difficulties, risks to people with HIV

Newswise:Video Embedded covid-19-a-wake-up-call-for-the-need-for-new-antiviral-weapons
VIDEO
Released: 26-May-2020 3:00 PM EDT
COVID-19: A wake-up call for the need for new antiviral weapons
Morgridge Institute for Research

Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.

19-May-2020 1:45 PM EDT
Combining Multiple Measures of Alcohol Use Helps Clarify Risky Drinking in People with HIV
Research Society on Alcoholism

Researchers and clinicians can better understand the health risks facing people with HIV through comprehensive measures of alcohol use, including objective biomarkers, according to a new study in Alcoholism: Clinical and Experimental Research. Frequent or heavy alcohol use in people with HIV can affect HIV disease progression and comorbidities. Alcohol use disorder is a barrier to effectively managing HIV and contributes in multiple ways to poor health outcomes. These effects are not well understood, however, owing in part to the limitations of self-report tools (questionnaires) for measuring alcohol use. Researchers at Louisiana State University and Tulane University correlated self-reported alcohol use, measured by multiple questionnaires, with a biomarker of alcohol consumption in people with HIV. This study explores the implications of this multi-faceted approach for understanding the alcohol use of people with HIV and the related risk factors.

Released: 7-May-2020 6:30 PM EDT
Dearth of Medical Resources in Africa for COVID-19 Reminiscent of Early HIV/AIDS Pandemic
Georgetown University Medical Center

Global health scholars have issued a clarion call about the needless loss of life expected because of a foreseeable prospect of “slow and inadequate access to supplies” to control COVID-19 in sub-Saharan Africa. They say what is unfolding now is similar to when lifesaving diagnostics and treatments came to the region long after they were available elsewhere.

Newswise: Research News Tip Sheet: Story Ideas From Johns Hopkins
Released: 30-Apr-2020 8:00 AM EDT
Research News Tip Sheet: Story Ideas From Johns Hopkins
Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every Tuesday throughout the duration of the outbreak.

Newswise: New University of Kentucky study could change what we know about platelets
Released: 29-Apr-2020 9:00 AM EDT
New University of Kentucky study could change what we know about platelets
University of Kentucky

The $6.6 million study will focus on how platelets function when they form clots in blood vessels and when they sense circulating pathogens, like viruses.

Newswise: Potential new HIV treatment could mean once-a-year injection
AUDIO
Released: 27-Apr-2020 12:55 PM EDT
Potential new HIV treatment could mean once-a-year injection
University of Nebraska Medical Center (UNMC)

The advance has the potential to eliminate complications that arise from missing doses of life-saving medicines, according to the study published today in Nature Materials, a leading peer-reviewed biomedical research journal.

Released: 20-Apr-2020 3:45 PM EDT
Africa in the path of COVID-19
Columbia University, Mailman School of Public Health

In a New England Journal of Medicine "Perspective" published today, Wafaa El-Sadr, MD, MPH, global director of ICAP at Columbia University Mailman School of Public Health, and Jessica Justman, MD, ICAP's senior technical director, and associate professor of epidemiology, urge a coordinated global effort in the face of the COVID-19 pandemic, with "countries around the world [taking] concrete steps to assist Africa in staying ahead of the curve, even as they confront their own epidemics."

Released: 7-Apr-2020 9:50 AM EDT
Depressive Disorders Are ‘Under Recognized and Under Treated’ in People with HIV/AIDS
Wolters Kluwer Health: Lippincott

People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Released: 11-Mar-2020 10:30 AM EDT
Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Mount Sinai Health System

Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally

Newswise: Curcumin is the spice of life when delivered via tiny nanoparticles
Released: 5-Mar-2020 8:05 AM EST
Curcumin is the spice of life when delivered via tiny nanoparticles
University of South Australia

For years, curry lovers have sworn by the anti-inflammatory properties of turmeric, but its active compound, curcumin, has long frustrated scientists hoping to validate these claims with clinical studies.

3-Mar-2020 3:50 PM EST
Shedding light on hidden HIV
Universite de Montreal

Initiating antiretroviral therapy at a very early stage makes HIV reservoirs shrink by 100 times, researchers in Canada, the U.S. and Thailand find.

Released: 26-Feb-2020 10:05 AM EST
Patients Better Informed About Health After HIV And HCV Tests That Give Immediate Results
Johns Hopkins University Carey Business School

When substance use disorder patients were tested for both HIV and hepatitis C virus at the same time and given the results within 20 minutes, they were far more likely a month later to indicate they had received results, compared with patients who were referred for testing services.

Newswise: Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Released: 26-Feb-2020 9:00 AM EST
Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Texas Biomedical Research Institute

More than $3.7 million was awarded to Mahesh Mohan, DVM, MS, Ph.D., Professor at the Texas Biomedical Research Institute, and Chioma M. Okeoma, Ph.D., Associate Professor at Stony Brook University, to explore the link between cannabinoids (THC) and chronic intestinal inflammation in patients infected with the human immunodeficiency virus (HIV).

Newswise: New clues emerge on how to block reemergence of HIV
Released: 12-Feb-2020 2:45 PM EST
New clues emerge on how to block reemergence of HIV
University of Washington School of Medicine

“We wanted to answer the question ‘How does HIV bounce back when treatment is stopped?'" said Dr. Florian Hladik.

Newswise: José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
Released: 10-Feb-2020 11:10 AM EST
José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
University of Pennsylvania School of Nursing

José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing, will be the next Chair of the University of Pennsylvania School of Nursing’s (Penn Nursing) Department of Family and Community Health, effective July 1, 2020.

Released: 10-Feb-2020 9:00 AM EST
Study Finds Innate Protein that Restricts HIV Replication by Targeting Lipid Rafts
George Washington University

A recent study from the George Washington University suggests that the innate protein AIBP restricts HIV-1 replications by targeting the lipid rafts the virus relies on.

Released: 6-Feb-2020 5:05 AM EST
Study Uses Powerful Sequencing Technology to Study HIV Epidemic in Washington, DC
George Washington University

Despite significant progress against HIV/AIDS, the nation’s capital is still battling an HIV epidemic with rates that are five times higher than the national average. A study published today in the journal Scientific Reports uses powerful next-generation sequencing technology to learn more about how the virus is spreading and developing drug resistance in the District of Columbia.

Released: 3-Feb-2020 7:05 PM EST
Tip Sheet: Tracking coronavirus, improving immunotherapies, cancer death rates decline, AAAS meeting and more
Fred Hutchinson Cancer Research Center

Summaries of recent Fred Hutch research studies, plus information on a press event at the upcoming AAAS annual meeting in Seattle.

31-Jan-2020 11:55 AM EST
HIV antibody therapy is associated with enhanced immune responses in infected individuals
Universite de Montreal

In a study in Nature Medicine, researchers describe how injection of neutralizing antibodies are associated with enhanced T cell responses that specifically recognize HIV.

Newswise: A Brain Link to STI/HIV Sexual Risk: Young women with Low Condom Use During Sex Find Visual Sexual Cues Less Pleasant and Less Evocative
Released: 27-Jan-2020 2:30 PM EST
A Brain Link to STI/HIV Sexual Risk: Young women with Low Condom Use During Sex Find Visual Sexual Cues Less Pleasant and Less Evocative
University of Pennsylvania School of Nursing

Data show that young adult women in the United States have high rates of sexually transmitted infections (STIs) that increase their risk of HIV. Though epidemiologic and behavioral factors for risk have been studied, we know very little about brain factors that may be linked to STI/ HIV sexual risk.

21-Jan-2020 11:10 AM EST
Researchers Reverse HIV Latency, Important Scientific Step Toward Cure
University of North Carolina School of Medicine

Overcoming HIV latency – activating HIV in CD4+ T cells that lay dormant – is a needed step toward a cure. Scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics – a partnership between UNC and ViiV Healthcare – showed it’s possible to drive HIV out of latency in two animal models.

Newswise: Blood Stem Cell Research
Released: 15-Jan-2020 2:05 PM EST
Blood Stem Cell Research
University of Delaware

A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware's Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body.

Newswise: Suo_photo.jpg
Released: 8-Jan-2020 4:15 PM EST
FSU study aids fight against HIV, hepatitis B
Florida State University

A discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 36 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B.

Released: 7-Jan-2020 5:45 PM EST
Intervention for patients hospitalized with HIV improved reengagement and outcomes of care
UT Southwestern Medical Center

Providing multidisciplinary team consults for HIV patients while they are hospitalized to help address social and medical barriers reduces future infection rates and boosts participation in follow-up care, results from a study on how to reengage patients show.


Showing results

150 of 1424

close
1.16966